Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
GILD
GILEAD SCIENCES, INC.
NASDAQ
$146.41
▲ UP 1.87% (2.69)

KEY STATISTICS

Market Cap$178.44 B
52w High$157.29
52w Low$108.46
Dividend Yield2.48%
FrequencyQuarterly
P/E-375.41
Volume4.92M
Shares Out.1.24B

COMPANY

LEADERSHIP

Daniel O'Day
CHIEF EXECUTIVE
Daniel O'Day

COMPENSATION 2026

Salary$1,795,192
Stock Awards$15,238,402
Incentive Plan Pay$4,848,120
All Other Comp.$2,055,424
Total$28,437,198

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 22, 1992
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
17,000

PRICE TARGET

Target High$175.00
Target Low$123.00
Target Median$150.00
Target Consensus$150.00

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$7.76B
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2013-01-28Forward2:1
2007-06-25Forward2:1
2004-09-07Forward2:1
2002-03-08Forward2:1
2001-02-22Forward2:1

PRICE

$146.41 ▲ UP 1.87% (+$2.69)
OVERLAYS
$144$145$146$1469:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM146.41

About Gilead Sciences, Inc.

https://www.gilead.com ↗

Gilead Sciences is a biopharma company developing medicines for HIV/AIDS, COVID-19, liver diseases, cancer, and other conditions, with global collaborations and a diverse product portfolio.

INDUSTRY

Drug Manufacturers - General

A PRODUCT GILEAD SCIENCES, INC. IS KNOWN FOR

Yeztugo (lenacapavir)
Yeztugo (lenacapavir)

Yeztugo, Gilead's twice-yearly injectable PrEP, offers a groundbreaking, infrequent-dosing HIV prevention option designed to improve adherence and expand the PrEP market.

COMPETITORS

COMPETITOR
BMY COMPARE
GSK COMPARE
JNJ COMPARE
MRK COMPARE
PFE COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1,347
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.22% · 39.5M
QQQ
0.80% · 26.4M
IVV.AX
0.27% · 15.9M
SPY.AX
0.27% · 15.2M
VIRS
12.12% · 3.1M
DGRW
1.40% · 1.6M
SCHX
0.26% · 1.3M
FTCS
2.16% · 1.1M
DUHP
1.21% · 1.0M
EMXC.DE
2.24% · 806.2K
QQQI
0.79% · 795.5K
TQQQ
0.31% · 760.7K
FHLC
2.55% · 616.8K
XDWH.DE
2.18% · 610.0K
QYLD
0.80% · 464.0K
CGBL
0.85% · 449.2K
AVLV
0.29% · 444.6K
XZ
XZME.F
0.66% · 428.3K
BBH
13.03% · 412.7K
JQUA
0.67% · 407.0K
WSRUS.SW
0.82% · 392.3K
ZSP.TO
0.27% · 389.0K
NDQ.AX
0.80% · 352.0K
GPIQ
0.79% · 309.5K
PB
PBPH
4.09% · 285.7K
HMWO.L
0.20% · 260.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
59.94%
HOLDERS
3,202
TOP 12 OF 3,202 · RANKED BY POSITION SIZE
Blackrock, Inc.
123.2M sh · $15.12B
Vanguard Group Inc
121.1M sh · $14.86B
Blackrock Inc.
120.6M sh · $8.28B
Fmr LLC
71.9M sh · $10.02B
State Street Corp
61.2M sh · $7.73B
Capital World Investors
45.2M sh · $5.02B
Invesco Ltd.
39.8M sh · $5.03B
Blackrock Institutional Trust Company, N.A.
36.9M sh · $2.65B
Jpmorgan Chase & Co
34.0M sh · $4.63B
Dodge & Cox
30.1M sh · $3.34B
Geode Capital Management, LLC
30.1M sh · $3.8B
Capital Research Global Investors
30.0M sh · $3.33B

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2026-08-10
 Jared Moskowitz
Jared Moskowitz
Purchase
2026-05-06
 Josh Gottheimer
Josh Gottheimer
Purchase
2026-01-27
 Josh S. Gottheimer
Josh S. Gottheimer
Purchase
2026-01-27

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Dickinson Andrew D
Purchase · 2.8K shares
2026-09-10
★
OFFICER: CHIEF FINANCIAL OFFICER
Dickinson Andrew D
Sale · 1.3K shares
2026-09-10
★
OFFICER: CHIEF FINANCIAL OFFICER
Dickinson Andrew D
Sale · 2.8K shares
2026-09-10
★
OFFICER: CHIEF MEDICAL OFFICER
Berger Dietmar
Sale · 533 shares
2026-09-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 7
OVERWEIGHT 4
SECTOR PERFORM 1
EQUAL WEIGHT 1
MARKET PERFORM 1
SECTOR OUTPERFORM 1
15 GRADES IN THE LAST 12 MONTHS
HSBC BUY Cantor Fitzgerald OVERWEIGHT RBC Capital SECTOR PERFORM Needham BUY Barclays EQUAL WEIGHT Morgan Stanley OVERWEIGHT Leerink Partners MARKET PERFORM Truist Securities BUY

SECTORS PEERS

PEERPRICE
MRK$145.41COMPARE
AMGN$379.29COMPARE
NVO$43.49COMPARE
PFE$27.75COMPARE
DHR$202.67COMPARE
BMY$64.07COMPARE
SYK$281.59COMPARE
SNY$43.45COMPARE